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We present the case of an 18-month-old boy with dysmorphic facial features, developmental delay, growth retardation, bilateral
clubfeet, thrombocytopenia, and strabismus, whose array CGH analysis revealed concurrent de novo trisomy 10p11.22p15.3 and
monosomy 7p22.3. We describe the patient’s clinical presentation, along with his cytogenetic analysis, and we compare the findings
to those of similar case reports in the literature. We also perform a bioinformatic analysis in the chromosomal regions of segmental
aneuploidy to find genes that could potentially explain the patient’s phenotype.
1. Introduction
Chromosomal abnormalities are common causes of multiple
congenital anomalies. Complete chromosomal trisomies and
monosomies of a few chromosomes (such as trisomy 21
and monosomy X) comprise the most common types of
chromosomal abnormalities. Partial chromosomal trisomies
and monosomies are less common, but are occasionally
accounted in individual case reports. In this article, we re-
port the case of a boy with partial trisomy 10p and partial
monosomy 7p revealed by comparative genomic hybridi-
zation (CGH) analysis. We describe the patient’s multiple
congenital anomalies, and compare them with those of
previously reported cases of either trisomy 10p or mono-
somy 7p. We also browse the patient’s chromosomal regions
of aneuploidy to find genes that could potentially give rise to
the patient’s signs and symptoms.
2. Case Presentation
The patient is an 18-month-old male born to a 29-year-old
G1P0 Native American mother and a 40-year-old Honduran
father at 40 weeks of gestation with several congenital
anomalies. Maternal past medical history was significant for
a history of a seizure disorder. She had not had a seizure in
three years and was no longer on antiseizure medication.
She did not take medications during pregnancy. There is no
known family history of major developmental disabilities in
either side of the family.
At time of birth, the patient’s Apgar scores were 6, 7, and
8 at 1, 5, and 10 minutes, respectively, weight of 2995 g (25th
percentile), length of 50 cm (50th percentile), and occipital-
frontal circumference (OFC) of 35 cm (30th percentile).
Dysmorphic features included bitemporal narrowing, a very
wide sagittal suture consistent with a bifid cranium with a
large sagittal and metopic suture, posteriorly rotated ears,
highly arched palate, micrognathia, frontal bossing, and
redundant skin on the neck with a low-lying hairline in the
posterior neck. Other findings of his physical examination
included hirsutism on the back, congenital hip and knee
dislocation bilaterally, bilateral clubfeet (status postcasting),
sacral dimples, and enlarged nipples. Abnormal labs included
thrombocytopenia (platelet count of 49,000 with normal
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values of 143,000 to 498,000), which spontaneously resolved.
Workup for infections including TORCH infections was
normal. He has had issues with recurrent otitis media.
Imaging tests, head, renal, and sacral ultrasound along
with skeletal survey X-rays were normal, and he passed the
newborn hearing screening.
Standard chromosome analysis detected an abnormal
male karyogram with additional chromosomal material
of unidentifiable origin at the end for the short arm of
one chromosome 7; 46,XY,add(7)(p22). Additional whole-
genome array-based comparative genomic hybridization
(aCGH) was performed on the proband and parental
peripheral blood samples using the CMDX Oligo HD Scan
to determine the origin of the additional material, and
its clinical significance. The array contains 99,000+ probes
covering coding and noncoding human genome sequences
with content sourced from the UCSC hg18 human genome
(NCBI build 36, March 2006) and an average probe spatial
resolution of ∼21Kb. Complete and partial karyograms
are shown in Figure 1. The patient’s aCGH analysis iden-
tified a copy number loss of approximately 0.5Mb of the
region 7p22.3 and gain of 33Mb of the short arm of
chromosome 10 (Figure 2). The karyotype is denoted as
arr 7p22.3(0-749,854)x1,10 p15.3p11.22 (0-33,408,955)x3,
10p11.22(33,039,622-33,408,955)x4 in accordance with the
ISCN2009. This result indicates a telomeric deletion of
7p22.3 and partial duplication of 10p11.22p15.3, a result
of a de novo unbalanced translocation. Parental karyo-
types and aCGH were normal. The final revised karyo-
type is described as 46,XY,der(7)t(7; 10)(p22.3; p11.22)
.arr 7p22.3(0-749,854)x1,10 p15.3p11.22 (0-33,408,955)x3,
10p11.22(33,039,622-33,408,955)x4 dn.
The patient was evaluated at the genetics clinic for
followup when he was 4.5 months old. On physical examina-
tion, the patient’s weight was 6.2 kg (10th to 25th percentile),
height was 66 cm (75th percentile), and OFC was 41.5 cm
(25th percentile). In general, he looked well-nourished and
in no acute distress. At this time, the patient was also noted
to have hypertelorism with strabismus. His developmental
milestones were delayed. He had some head control, and was
starting to spend time with his face down, playing with his
hands, cooing, making noises, and taking his hands to the
midline grabbing at objects.
On followup evaluation at 13.5 months of age, he was
found to still have developmental delay. The patient had
been receiving visual therapy for his strabismus (specifically,
esotropia), which was noted to be improving, and he was
followed regularly in an ophthalmology clinic. He was also
monitored routinely by orthopedics for his lower extremity
anomalies, for which he had underwent postnatal, corrective
surgeries.
At the most recent genetics evaluation, he was 27
months of age and doing well. He had recurrent infections
including otitis media, upper respiratory infections, and
aspiration pneumonia. He had recently been diagnosed
with asthma. He was growing well and gaining weight
easily. He continued to have developmental delay and at
27 months was able to commando crawl and say a few
words.
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Figure 1: Patient’s complete and partial (boxed, different band
resolutions) GPG-banded karyograms, displays extraneous chro-
mosomal material at the telomere of chromosome 7p.
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Figure 2: Oligonucleotide-aCGH profile for chromosome 10. The
ideogram (lower part) depicts the entire chromosome 10. The
33Mb gain interval at 10p11.22p15.3 [hg18,chr10: 0-33,408,955 bp]
detected in this patient is indicated by two vertical blue bars, and the
log2 ratio of +1.
3. Discussion
Individual cases of partial trisomy 10p11.22p15.3 andmono-
somy 7p22.3 have been previously reported in the literature.
The combination of the two in a single patient, however,
has not been reported. The first case of trisomy 10p, due
to an unbalanced t(7; 10) (p22; p11) translocation, was
that of two siblings described by Schleiermacher et al.
1974 [1], which have the same region of 10p trisomy and
monosomy 7p as our patient (see Table 1). However, at
the time of this study, the method of detection was only
through standard karotyping, which makes the comparison
of gene contribution difficult, and therefore the genotype-
phenotype correlation has never been studied before. Since
then, several investigators have reported tens of cases of
trisomy 10p with some similar and other new phenotypic
features. We compared the phenotypic findings in our
patient with those of other patients with pure trisomy 10p
(since our patient’s region of trisomy covers almost all of
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Table 1: Phenotypic findings in our patient and patients reported in the literature with either pure trisomy 10p11.2p15.3 or monosomy
7p22.
Name/case Present case Schleiermacher et al. [1]a Granata et al. [2]
Schomig-Spingler et al.
[3]
Gender Male Male+ Female Mixed Mixed
Genotype 10p+, 7p− 10p+ 10p+ 7p−
Growth retardation + + 9/9 ND
High-arched palate + + 7/9 7/12
Wide fontanelle(s) + + 6/9 ND
Hypertelorism + ND 5/9 2/12b
Micrognathia + ND 5/9 ND
Feet anomaly + + 4/9 6/12
Thrombocytopenia + ND 1/9 ND
Posterior ear rotation + + ND 1/12
Detection method aCGH Karyotype Karyotype Karyotype
a
This paper describes the first case of 10p trisomy, with the same breakpoints as in our patient’s case.
bThe patients were reported to have either hyper- or hypotelorism.
ND: not described.
the short arm of chromosome) and monosomy 7p22.3. The
results are shown in Table 1. It should be noted that the
0.37 Kb genomic region on 10p11.22, of which four copies
were found in our patient, may point to a normal genomic
variation that our method has been able to detect, as searches
for this variation in the Database of Genomic Variants
(http://projects.tcag.ca/variation/) and the Children’s Hospi-
tal of Philadelphia (CHOP) copy number variation database
(http://cnv.chop.edu/) did not yield any overlapping results.
Our patient’s signs and symptoms, including his early
growth retardation, feet anomaly, low platelet count, wide
fontanelle, high-arched palate, micrognathia, and hyper-
telorism, have been previously associated with trisomy 10p in
various case reports [1, 2, 6, 7]. Posterior ear rotation has also
been reported to be associated with some cases of monosomy
7p in the past [3]. Our patient’s phenotypic findings are
therefore mainly due to his trisomy 10p, with the possible
exception of his posterior ear rotation, which may have
resulted from his 7pmicrodeletion. In addition to comparing
our patient’s case to others in the literature, we also
searched the Database of Chromosomal Imbalance and Phe-
notype in Humans Using Ensembl Resources (DECIPHER;
http://decipher.sanger.ac.uk/) for chromosomal aberrations
in the affected chromosomal locations. Althoughmany of the
cases in the database reported nonspecific or no phenotypic
information, several (on chromosome 10p, ranging from
145Kb to 36.8Mb) mentioned developmental delay as well
as micrognathia, hypertelorism, and anomalies in the skin
and feet, in agreement with our case.
These types of rearrangements are due to 2; 2 malseg-
regation during meiosis I, adjacent 1, single segment is the
most likely type of malsegregation underlying this patient’s
unbalanced translocation, because one of the segments or the
portions exchanged, on chromosome 7, is smaller (0.5Mb)
compared to the chromosome 10 segment [8]. The 33Mb
region of chromosome 10p, which our patient has gained a
single copy of, contains several RefSeq genes (>500), some
of which could have potentially played a role in his multiple
congenital anomalies. We identified three of these genes
(Table 2), whose protein products’ functions are known and
are possibly related to the patient’s clinical presentation,
including but not limited to his hematological (PFKP, TAF3)
and possible hearing (MYO3A) signs and symptoms. PFKP,
encoding the platelet isoform of the key regulatory phos-
phofructokinase enzyme, and TAF3, coding for an important
member of the molecular transcription machinery, reported
to be necessary for early hematopoiesis [4], are potential can-
didate genes for our patient’s transient thrombocytopenia.
TAF3’s contribution to skeletal muscle development [5] may
also at least partially explain our patient’s clubfeet presenta-
tion. OPTN, though mostly recognized in the literature for
its role in the pathophysiology of glaucoma [9, 10], may be a
potential candidate gene for our patient’s visual symptoms
including strabismus, through unknown mechanisms. It
should also be noted that it is critical for our patient to be
continuously evaluated for his hearing since loss of function
mutations in MYO3A, a member of the myosin superfamily
of genes on chromosome 10p, have been linked to progressive
nonsyndromic hearing loss [11].
Investigation of the few genes in the region of monosomy
for chromosome 7p also revealed FAM20C and platelet-
derived growth factor alpha (PDGFA), as genes that have
potential roles in our patient’s developmental delay and
bone findings. FAM20C has been shown to be important
for normal bone development, as individuals with loss of
function mutations in the gene suffer from Raine syndrome,
a fatal bone disorder [12]. Patients with less severe mutations
in FAM20C have been reported to have wide fontanelles,
as in our patient [13]. PDGFA is also a critical gene for
development, particularly for oligodendrocytes, as knockout
mice have been observed to die soon after birth or as
embryos, most probably due to myelin loss from abnormal
oligodendrocyte development [14], making it a potential
candidate gene for our patient’s developmental delay.
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Table 2: Potentially causative genes on chromosome 10p11.22p15.3 that may play a role in our patient’s phenotypic findings.
Gene Name OMIM ID Gene description Gene product function Relation to patient’s phenotype
PFKP 171840
Homo sapiens
phosphofructokinase, platelet
(PFKP), mRNA
Encodes the platelet isoform of
phosphofructokinase (PFK), a
key regulatory enzyme in
glycolysis. This gene is also
expressed in fibroblasts.
Thrombocytopenia
TAF3 606576
Homo sapiens TAF3 RNA
polymerase II, TATA box binding
protein (TBP)-associated factor,
mRNA
A critical member of the highly
conserved transcription factor
machinery, TAF3 has been found
to be involved in early
development and hematopoiesis
[4] as well as skeletal muscle
differentiation [5].
Thrombocytopenia, clubfeet
MYO3A 606808
Homo sapiens, Myosin IIIA,
mRNA
Encodes a member of the myosin
superfamily. This particular
protein product is strongly
expressed in the cochlea and the
retina. Loss of function
mutations have been reported to
contribute to nonsyndromic
progressive hearing loss.
Possibly progressing hearing
impairment, need for regular
checkups
The relatively large region of trisomy on chromosome
10p, in addition to monosomy 7p, has caused several
congenital anomalies in our patient, which affect almost
all of his organ systems. Other examples of concurrent
partial trisomy and monosomy of other chromosomes
detected by array CGH, prenatally or postnatally, have been
previously described in the literature [15]. Although the
exact causes of the patient’s single findings are unknown,
we were able to identify the nature of the chromosomal
abnormalities. We also identified six potential candidate
genes (PFKP, TAF3, OPTN, MYO3A, FAM20C, and PDGFA),
among ∼500 genes in the patient’s affected chromosomal
regions, which can possibly explain several of his develop-
mentally related signs and symptoms. More patients like
ours are expected to be identified through the current
use of this powerful, genome-wide, high-resolution array
technology. The description of the phenotype and the
followup of such patients are critical for the understanding
of these new conditions and the counseling of new affected
patients. Further research is needed to identify the exact
mechanisms by which these genes can cause such clinical
findings.
Acknowledgments
The authors thank the patient’s family for their permission
to publish this case. They also thank Mrs. Gloria Lan at
the UCLA clinical and molecular cytogenetics laboratory
for her technical assistance. This paper makes use of data
generated by the DECIPHER Consortium. A full list of
centres that contributed to the generation of the data is
available from http://decipher.sanger.ac.uk/ and via email
from decipher@sanger.ac.uk. Funding for the paper was
provided by the Wellcome Trust.
References
[1] E. Schleiermacher, U. Schliebitz, and C. Steffens, “Brother and
sister with trisomy 10p: a new syndrome,” Humangenetik, vol.
23, no. 3, pp. 163–172, 1974.
[2] P. Granata, D. Mazzola, R. Righi et al., “Molecular cytogenet-
ics, RFLP analysis and clinical characterization of a de novo
trisomy 10p case,” Annales de Genetique, vol. 43, no. 1, pp. 45–
50, 2000.
[3] M. Schomig-Spingler, M. Schmid, W. Brosi, and T. Grimm,
“Chromosome 7 short arm deletion, 7p21→pter,” Human
Genetics, vol. 74, no. 3, pp. 323–325, 1986.
[4] D. O. Hart, M. K. Santra, T. Raha, and M. R. Green, “Sel-
ective interaction between Trf3 and Taf3 required for early
development and hematopoiesis,” Developmental Dynamics,
vol. 238, no. 10, pp. 2540–2549, 2009.
[5] M. D. Deato and R. Tjian, “An unexpected role of TAFs
and TRFs in skeletal muscle differentiation: switching core
promoter complexes,” Cold Spring Harbor Symposia on Quan-
titative Biology, vol. 73, pp. 217–225, 2008.
[6] Th. W. J. Hustinx, B. G. A. Ter Haar, J. M. J. C. Scheres, and F.
J. Rutten, “Trisomy for the short arm of chromosome No. 10,”
Clinical Genetics, vol. 6, no. 5, pp. 408–415, 1974.
[7] P. de Chieri, E. Spatuzza, and J. M. Bonich, “Brother and sister
with trisomy 10p,” Human Genetics, vol. 45, no. 1, pp. 71–75,
1978.
[8] P. Jalbert, B. Sele, and H. Jalbert, “Reciprocal translocations:
a way to predict the mode of imbalanced segregation by
pachytene-diagram drawing,” Genetics, vol. 55, no. 2, pp. 209–
222, 1980.
[9] M. Sarfarazi and T. Rezaie, “Optineurin in primary open angle
glaucoma,” Ophthalmology Clinics of North America, vol. 16,
no. 4, pp. 529–541, 2003.
[10] J. L. Wiggs, J. Auguste, R. R. Allingham et al., “Lack of asso-
ciation of mutations in optineurin with disease in patients
with adult-onset primary open-angle glaucoma,” Archives of
Ophthalmology, vol. 121, no. 8, pp. 1181–1183, 2003.
Case Reports in Genetics 5
[11] T. Walsh, V. Walsh, S. Vreugde et al., “From flies’ eyes
to our ears: mutations in a human class III myosin cause
progressive nonsyndromic hearing loss DFNB30,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 99, no. 11, pp. 7518–7523, 2002.
[12] M. A. Simpson, R. Hsu, L. S. Keir et al., “Mutations
in FAM20C are associated with lethal osteosclerotic bone
dysplasia (Raine syndrome), highlighting a crucial molecule
in bone development,” American Journal of Human Genetics,
vol. 81, no. 5, pp. 906–912, 2007.
[13] M. A. Simpson, A. Scheuerle, J. Hurst, M. A. Patton, H.
Stewart, and A. H. Crosby, “Mutations in FAM20C also
identified in non-lethal osteosclerotic bone dysplasia,” Clinical
Genetics, vol. 75, no. 3, pp. 271–276, 2009.
[14] M. Fruttiger, L. Karlsson, A. C. Hall et al., “Defective
oligodendrocyte development and severe hypomyelination in
PDGF-A knockout mice,” Development, vol. 126, no. 3, pp.
457–467, 1999.
[15] S. Brisset, S. Kasakyan, A. C. L’Hermine´ et al., “De novo mono-
somy 9p24.3-pter and trisomy 17q24.3-qter characterised by
microarray comparative genomic hybridisation in a fetus with
an increased nuchal translucency,” Prenatal Diagnosis, vol. 26,
no. 3, pp. 206–213, 2006.
